Drug shortages

Gadobutrol Injection

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

To Be Discontinued65219-281-02Medical Imaging
Open FDA's page for this record
Discontinued date
06/30/2026
Update type
New
Initial posting date
06/30/2026
Package NDC
65219-281-02
Generic name
Gadobutrol Injection
Contact info
888-386-1300
Update date
06/30/2026
Dosage form
Injection
Presentation
Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-02)
Company name
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Status
To Be Discontinued
Related info

Discontinuance of single dose vials, the other two Imaging Bulk Package(IBP) strengths are to remain in supply: the IBP strengths (18.1416 g/30 mL and 39.3068 g/65 mL); Marketed by Fresenius Kabi, USA

Therapeutic category
Medical Imaging
Harmonized identifiers (openFDA)
Application number
ANDA215061
Brand name
GADOBUTROL
Generic name
GADOBUTROL
Manufacturer name
Fresenius Kabi USA, LLC
Product NDC
65219-281
Product type
HUMAN PRESCRIPTION DRUG
Route
INTRAVENOUS
Substance name
GADOBUTROL
SPL ID
490c8c3e-3195-40af-8f34-40d8df2719c3
SPL set ID
007696d0-4b62-4937-9640-4ad619504df4
Package NDC
65219-281-00, 65219-281-02, 65219-281-03, 65219-281-07, 65219-281-08, 65219-281-10, 65219-281-05, 65219-281-15
Nui
N0000183362, N0000175862
Pharm class epc
Gadolinium-based Contrast Agent [EPC]
Pharm class moa
Magnetic Resonance Contrast Activity [MoA]
UNII
1BJ477IO2L
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.